Home / Olmesartan Medoxomil / Canada
CA ATC C09CA08 · updated 2 Nov 2026
Olmesartan Medoxomil shortage in Canada
Is there an Olmesartan Medoxomil shortage in Canada?
Yes. As of 2 Nov 2026, 3 Olmesartan Medoxomil products are reported short in Canada, the first since 7 May 2024. The company estimate for the return is 27 Nov 2026. Main reason: manufacturing problem.
Also short in Italy, Spain, Belgium, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-OLMESARTAN (90 BTL) | APOTEX INC | 7 May 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-OLMESARTAN (90 BTL) | APOTEX INC | 12 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | GLN-OLMESARTAN (30's) | GLENMARK PHARMACEUTICALS CANADA INC. | 29 Oct 2026 | 27 Nov 2026 | Increased demand Demand increase for the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.